Reported Sep 25, 2024 · Ongoing
AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only, Distributed by: Advagen Pharma Limited, Plainsboro, NJ,…
Rubicon Research Private Limited
Low riskThis product is unlikely to cause harm, but it breaks a safety or labelling rule.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Rubicon Research Private Limited · 4 & K30 5 Plot No K - 30 · Ambarnath · N/A
Is this the product you have?
- AcetaZOLAMIDE Tablets, USP, 125 mg, 100 count bottled, Rx Only
- Distributed byAdvagen Pharma Limited, Plainsboro, NJ, Manufactured by Rubicon Research Private Limited, Thane, India NDC 72888-047-01
- Lot codes and dates
Lot # 30575HF1exp. dateNov 2026 NDC# 72888-047-01
- Amount recalled
- 3,984 bottles
Where it was sold
- Nationwide
Why it was recalled
Discoloration
This product is unlikely to cause harm, but it breaks a safety or labelling rule.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Rubicon Research Private Limited recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.